Handelsbanken Fonder AB Raises Stake in Axon Enterprise, Inc $AXON

Handelsbanken Fonder AB boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 9.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 65,590 shares of the biotechnology company’s stock after acquiring an additional 5,423 shares during the period. Handelsbanken Fonder AB owned about 0.08% of Axon Enterprise worth $47,070,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Axon Enterprise by 4.2% during the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after purchasing an additional 376,904 shares in the last quarter. Geode Capital Management LLC raised its stake in Axon Enterprise by 5.9% in the second quarter. Geode Capital Management LLC now owns 2,072,186 shares of the biotechnology company’s stock valued at $1,713,332,000 after buying an additional 115,349 shares in the last quarter. Jennison Associates LLC lifted its holdings in Axon Enterprise by 53.8% during the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after buying an additional 330,213 shares during the last quarter. Vestor Capital LLC boosted its position in shares of Axon Enterprise by 438,636.3% during the 2nd quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock worth $690,170,000 after acquiring an additional 833,409 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Axon Enterprise during the 2nd quarter worth about $637,806,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Needham & Company LLC cut their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a research report on Friday, February 20th. Royal Bank Of Canada dropped their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research note on Wednesday. UBS Group reduced their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research report on Wednesday. Citigroup restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday. Finally, Craig Hallum reiterated a “buy” rating and set a $820.00 price target on shares of Axon Enterprise in a research note on Wednesday. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $762.93.

Insiders Place Their Bets

In other news, CAO Jennifer H. Mak sold 1,134 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $600.00, for a total transaction of $680,400.00. Following the completion of the sale, the chief accounting officer owned 13,740 shares in the company, valued at $8,244,000. This represents a 7.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 1,797 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total value of $968,996.31. Following the sale, the insider directly owned 83,485 shares of the company’s stock, valued at approximately $45,017,616.55. This represents a 2.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 58,040 shares of company stock valued at $32,251,738. 4.40% of the stock is owned by company insiders.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and bullish bookings — Axon reported a double beat (EPS and revenue), ~39% revenue growth and a material increase in future contracted bookings with raised multi‑year sales targets, which triggered the stock rally. Read More.
• Positive Sentiment: AI narrative driving subscription demand — Coverage highlights that Axon’s AI features (body‑camera analytics, Draft One report drafting, evidence management) are accelerating software adoption and upsells, supporting revenue visibility beyond hardware. Read More.
• Neutral Sentiment: Analysts recalibrating models — Several firms trimmed price targets after the print (Piper Sandler, others); many maintained buy/overweight stances, so these moves reflect model updates and volatility rather than a wholesale negative verdict. Read More.
• Neutral Sentiment: Short‑interest data flagged as anomalous — Recent short‑interest reports show zero/NaN figures (likely a reporting anomaly); nothing actionable from that data point for now.
• Negative Sentiment: Some analysts flag downside risk — Morgan Stanley and UBS issued more cautious outlooks/pessimistic scenarios that could cap upside if execution or margins slip. Read More. | Read More.
• Negative Sentiment: Profitability and margin recovery remain a watch item — Commentators note fast revenue growth but slower profit improvement and the need for FCF conversion; sustained margin progress is required to justify high multiples. Read More.
• Negative Sentiment: Insider sale disclosed — CEO Patrick Smith sold 10,000 shares (~$5.0M) on Feb. 25; small relative to his holdings but notable to traders monitoring insider activity. Read More.

Axon Enterprise Trading Down 1.4%

NASDAQ AXON opened at $542.40 on Friday. The firm’s fifty day moving average is $537.92 and its two-hundred day moving average is $625.54. Axon Enterprise, Inc has a one year low of $396.41 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.89 and a current ratio of 2.53. The firm has a market cap of $43.61 billion, a PE ratio of 356.84, a P/E/G ratio of 16.57 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The firm had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business’s revenue was up 38.5% on a year-over-year basis. During the same quarter last year, the company posted $2.08 earnings per share. Analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.